Marsh & McLennan (Marsh & McLennan) Change In Receivables

: $-434 Mil (TTM As of Mar. 2024)

View and export this data going back to 1969. Start your Free Trial

Marsh & McLennan's change in receivables for the quarter that ended in Mar. 2024 was $-742 Mil. It means Marsh & McLennan's Accounts Receivable increased by $742 Mil from Dec. 2023 to Mar. 2024 .

Marsh & McLennan's change in receivables for the fiscal year that ended in Dec. 2023 was $-467 Mil. It means Marsh & McLennan's Accounts Receivable increased by $467 Mil from Dec. 2022 to Dec. 2023 .

Marsh & McLennan's Accounts Receivable for the quarter that ended in Mar. 2024 was $6,509 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Marsh & McLennan's Days Sales Outstanding for the three months ended in Mar. 2024 was 91.76.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Marsh & McLennan's liquidation value for the three months ended in Mar. 2024 was $-28,616 Mil.

Marsh & McLennan Change In Receivables Historical Data

The historical data trend for Marsh & McLennan's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marsh & McLennan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-130.00

-75.00

-570.00

-492.00

-467.00

Marsh & McLennan Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables																-775.00	-254.00	359.00	203.00	-742.00

Marsh & McLennan Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-434 Mil.

Marsh & McLennan (NYSE:MMC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Marsh & McLennan's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	6509	/	6473	*	91
=	91.76

2. In Ben Graham's calculation of liquidation value, Marsh & McLennan's accounts receivable are only considered to be worth 75% of book value:

Marsh & McLennan's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1452	-	34950	+	0.75 * 6509	+	0.5 * 0
=	-28,616

Marsh & McLennan Change In Receivables Related Terms

Thank you for viewing the detailed overview of Marsh & McLennan's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Marsh & McLennan (Marsh & McLennan) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Marsh & McLennan Companies Inc (NYSE:MMC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

MMC:Mexico MSN:Germany MSN:Germany M1MC34:Brazil MMCO:Austria MMC:Argentina

Address

1166 Avenue of the Americas, New York, NY, USA, 10036-2774

Website

https://www.marshmclennan.com

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the U.S.

Executives

Oscar Fanjul	director	C/O OMEGA CAPITAL, S.L., PASEO DE LA CASTELLANA, 28, MADRID U3 28046
John Jude Jones	officer: Chief Marketing Officer	1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Dean Michael Klisura	officer: President & CEO, Guy Carpenter	1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Steven A Mills	director	IBM CORPORATION, 294 ROUTE 100, SOMERS NY 10589
Mark C Mcgivney	officer: Chief Financial Officer
Judith Hartmann	director	1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Ray G Young	director	77 WEST WACKER DR., SUITE 4600, CHICAGO IL 60601
Stacy Mills	officer: Vice President and Controller	C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENENUE OF THE AMERICAS, NEW YORK NY 11102
Paul Beswick	officer: SVP, Chief Information Officer	1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martin South	officer: President & CEO, Marsh	1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martine Ferland	officer: President and CEO, Mercer	C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Katherine Brennan	officer: SVP and General Counsel	1166 AVENUE OF THE AMERICAS, 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Daniel S Glaser	officer: Chairman & CEO, Marsh	C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Hafize Gaye Erkan	director	727 FIFTH AVENUE, NEW YORK NY 10022
Marc D Oken	director	C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202